N+1 Singer reiterated their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research report released on Friday morning. They currently have a GBX 1,350 ($17.62) target price on the stock.

Analyst Recommendations for Dechra Pharmaceuticals plc (LON:DPH)

Several other research firms have also recently issued reports on DPH. Jefferies Group increased their target price on Dechra Pharmaceuticals plc from GBX 1,229 ($16.04) to GBX 1,295 ($16.90) and gave the stock a  hold rating in a research report on Wednesday, September 7th. Investec increased their target price on Dechra Pharmaceuticals plc from GBX 1,300 ($16.97) to GBX 1,400 ($18.27) and gave the stock a buy rating in a research report on Monday, September 5th. Stifel Nicolaus reiterated a hold rating and set a GBX 1,250 ($16.32) target price on shares of Dechra Pharmaceuticals plc in a research report on Monday, September 5th. Numis Securities Ltd reiterated an add rating and set a GBX 1,320 ($17.23) target price on shares of Dechra Pharmaceuticals plc in a research report on Wednesday, August 17th. Finally, FinnCap reiterated an under review rating on shares of Dechra Pharmaceuticals plc in a research report on Tuesday, August 30th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Dechra Pharmaceuticals plc currently has an average rating of Buy and a consensus price target of GBX 1,255.63 ($16.39).

Shares of Dechra Pharmaceuticals plc (LON:DPH) opened at 1364.00 on Friday. The firm has a 50-day moving average price of GBX 1,348.78 and a 200 day moving average price of GBX 1,209.08. The company’s market cap is GBX 1.27 billion. Dechra Pharmaceuticals plc has a 12 month low of GBX 811.00 and a 12 month high of GBX 1,423.00.

The business also recently disclosed a dividend, which will be paid on Friday, November 18th. Stockholders of record on Thursday, October 27th will be paid a GBX 12.91 ($0.17) dividend. This represents a dividend yield of 0.92%. This is a positive change from Dechra Pharmaceuticals plc’s previous dividend of $5.55. The ex-dividend date is Thursday, October 27th.

About Dechra Pharmaceuticals plc

Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company. The Company is engaged in the development, manufacture and marketing of products for veterinarians across the world. The Company’s segments include European Pharmaceuticals, consists of Dechra Veterinary Products EU and Dechra Pharmaceuticals Manufacturing; North American (NA) Pharmaceuticals, consists of Dechra Veterinary Products US and Dechra Veterinary Products Canada, and Pharmaceuticals Research and Development.

Receive News & Ratings for Dechra Pharmaceuticals plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dechra Pharmaceuticals plc and related companies with MarketBeat.com's FREE daily email newsletter.